PATENT CLAIM ANALYSIS

Application Number: 16116425
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["544", "262000"]

Abstract:
Disclosed herein are processes for preparing 2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]pyiperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile free base (compound (I)), salts of compound (I) and solid state form of said salts. Also disclosed herein are pharmaceutical compositions comprising such salts and solid state form thereof and methods of treating cancer, autoimmune, and inflammatory diseases using compound (I) or a pharmaceutically acceptable salt thereof.

Claim (Index 21):
The amorphous form of the pharmaceutically acceptable salt of the at least one compound of  claim 20 , wherein the pharmaceutically acceptable salt is a sulfonic acid or a carboxylic acid salt.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.67857
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15120293', '14464602', '14997330', '15978041', '14374788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940557242238201
- 35 USC 102 Novelty (BERT): 0.5565464660372013
- Combined Prediction Score: 0.7703047984051582
- Mean Citation Score: 413.825286
- Max Citation Score: 468.8982
- Similarity Product: 282.1806285260439

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test